Teratogenic response to arsenite during neurulation: Relative sensitivities of C57BL/6J and SWV/Fnn mice and impact of the splotch allele

Toxicological Sciences

Volumn 51, Issue 1, 1999, Pages 98-107

  Machado, A F ^a   Hovland Jr , D N ^a   Pilafas, S ^a   Collins, M D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arsenic; C57BL 6J mice; Exencephaly; Pax3; Spina bifida aperta; Splotch; SWV mice; Teratology

Indexed keywords

ARSENITE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH DEFECT; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; MALE; MOUSE; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; SKELETON MALFORMATION; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ARSENITES; BONE AND BONES; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETAL DEATH; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NERVOUS SYSTEM; PREGNANCY; SEX DISTRIBUTION; SODIUM COMPOUNDS; SPECIES SPECIFICITY; SPINA BIFIDA CYSTICA; TERATOGENS;

EID: 0032871272     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/51.1.98     Document Type: Article

References (76)

1. Aschengrau, A., Zierler, S., and Cohen, A. (1989). Quality of community drinking water and the occurrence of spontaneous abortion. Arch. Environ. Health 44, 283-290.
2. Auerbach, R. (1954). Analysis of the developmental effects of a lethal mutation in the house mouse. J. Exp. Zool. 127, 305-329.
3. Baxley, M. N., Hood, R. D., Vedel, G. C., Harrison, W. P., and Szczech, G. M. (1981). Prenatal toxicity of orally administered sodium arsenite in mice. Bull. Environm. Contam. Toxicol. 26, 749-756.
4. Beaudoin, A. R. (1974). Teratogenicity of sodium arsenate in rats. Teratology 10, 153-157.
5. Borzsonyi, M., Bereczky, A., Rudnai, P., Csanady, M., and Horvath, A. (1992). Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch. Toxicol. 66, 77-78.
6. Carpenter, S. J. (1987). Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos. Anat. Embryol. (Berl.) 176, 345-65.
7. Chaineau, E., Binet, S., Pol, D., Chatellier, G., and Meininger, V. (1990). Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. Teratology 41, 105-112.
8. Chen, W., Martindale, J. L., Holbrook, N. J., and Liu, Y. (1998). Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol. Cell. Biol. 18, 5178-5188.
9. Collins, M. D., Scott, W. J., Miller, S. J., Evans, D. A., and Nau, H. (1992). Murine teratology and pharmacokinetics of the enantiomers of sodium 2-ethylhexanoate. Toxicol. Appl. Pharmacol. 12, 257-265.
10. Copp, A. J., Brook, F. A., Estibeiro, J. P., Shum, A. S. W., and Cockroft, D. L. (1990). The embryonic development of mammalian neural tube defects. Prog. Neurobiol. 35, 363-403.
11. Couse, J. F., Davis, V. L., Tally, W. C., and Korach, K. S. (1994). An improved method of genomic DNA extraction for screening transgenic mice. Biotechniques 17, 1030-1032.
12. Dagg, C. P. (1966). Teratogenesis. In Biology of the Laboratory Mouse (E. L. Green, Ed.), pp. 309-328. McGraw-Hill, New York.
13. Daston, G., Lamar, E., Olivier, M., and Goulding, M. (1996). Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 122, 1017-27.
14. Del Razo, L. M., Arellano, M. A., and Cebrian, M. E. (1990). The oxidation states of arsenic in well water from a chronic arsenicism area of northern Mexico. Environ. Pollut. 64, 143-153.
15. DeSesso, J. M., Jacobson, C. F., Scialli, A. R., Farr, C. H., and Holson, J. F. (1998). An assessment of the developmental toxicity of inorganic arsenic. Reprod. Toxicol. 12(4), 385-433.
16. DiGeorge, A. M., Olmsted, R. W., and Robinson, D. H. (1960). Waardenburg syndrome. J. Pediatr. 57, 649-699.
17. Elwood, J. M., and Elwood, J. H. (1980). Epidemiology of Anencephalus and Spina Bifida, p. 134. Oxford University Press, Oxford, U.K.
18. Epstein, D. J., Vogan, K. J., Trasler, D. G., and Gros, P. (1993). A mutation within intron 3 of the Pax3 gene produces aberrantly spliced mRNA transcripts in the Splotch (Sp) mouse mutant. Proc. Natl. Acad. Sci. U S A 90, 532-536.
19. Estibeiro, J. P., Brook, F. A., and Copp, A. J. (1993). Interaction between Splotch (Sp) and curly tail (ct) mouse mutants in the embryonic development of neural tube defects. Development 119, 113-121.
20. Ferm, V. H., and Carpenter, S. J. (1968). Malformations induced by sodium arsenate. J. Reprod. Fertil. 17, 199-201.
21. Ferm, V. H., Saxon, A., and Smith, B. M. (1971). The teratogenic profile of sodium arsenate in the golden hamster. Arch. Environ. Health 22, 557-560.
22. Finnell, R. H., Bennett, G. D., Karras, S. B., and Mohl, V. K. (1988). Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology 38, 313-320.
23. Finnell, R. H., and Chernoff, G. (1985). Common hierarchies of susceptibility to teratogen-induced neural tube defects in the mouse. Proc. Grnwd. Genet. Ctr. 5, 162-163.
24. Finnell, R. H., Moon, S. P., Abbott, L. C., Golden, J. A., and Chernoff, G. F. (1986). Strain differences in heat-induced neural tube defects in mice. Teratology 33, 247-252.
25. Foy, C., Newton, V., Wellesley, D., Harris, R., and Read, A. P. (1990). Assignment of the locus for Waardenburg syndrome type I to human chromosome 2q37 and possible homology to the splotch mouse. Am. J. Hum. Genet. 46,1017-1023.
26. Gale, T. F., and Layton, W. M., Jr. (1978). A variable embryotoxic response to lead in different strains of hamsters. Environ.. Res. 17, 325-333.
27. Golub, M. S., Macintosh, M. S., and Baumrind, N. (1998). Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J. Toxicol. Environ. Health, B Crit. Rev. 1, 199-241.
28. Goulding, M., Sterrer, S., Fleming, J., Balling, R., Nadeau, J., Moore, K. J., Brown, S. D., Steel K. P., and Gruss, P. (1993). Analysis of the Pax-3 gene in the mouse mutant Splotch. Genomics 17, 355-363.
29. Gruss, P., and Walther, C. (1992). Pax in development. Cell 69, 719-722.
30. Harris, M. J., and Juriloff, D. M. (1997). Genetic landmarks for defects in mouse neural tube closure. Teratology 56, 177-187.
31. Hood, R. D. (1972). Effects of sodium arsenite on fetal development. Bull. Environm. Contam. Toxicol. 7(4), 216-222.
32. Hood, R. D., and Bishop, S. L. (1972). Teratogenic effects of sodium arsenate in mice. Arch. Environ. Health 24, 62-65.
33. Hood, R. D., and Harrison, W. P. (1982). Effects of prenatal arsenite exposure in the hamster. Bull. Environm. Contam. Toxicol. 29, 671-678.
34. Hood, R. D., Thacker, G. T., and Patterson, B. L. (1978). Prenatal effects of oral versus intraperitoneal sodium arsenate in mice. J. Environ. Pathol. Toxicol. 1, 857-864.
35. Hoth, C. F., Milunsky, A., Lipsky, N., Sheffer, R., Clarren, S. K., and Baldwin, C. T. (1993). Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52, 455-462.
36. Hovland, Jr., D. N., Machado, A. F., Scott, Jr., W. J., and Collins, M. D. (1999). Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. Teratology 60, 13-21.
37. Inouye, M. (1976). Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S. Cong. Anom. 16, 171-173.
38. International Agency for Research on Cancer (1987). Arsenic and Arsenic Compounds. IARC Monographs. IARC, Lyon.
39. Juriloff, D. M., Harris, M. J., Tom, C., and MacDonald, K. B. (1991). Normal mouse strains differ in the site of initiation of closure of the cranial neural tube. Teratology 44, 225-233.
40. Kaiser, J. (1998). Toxicologists shed new light on old poisons. Science 279, 1850-1851.
41. Kalter, H. (1965). Interplay of intrinsic and extrinsic factors. In Teratology. Principles and Techniques (J. G. Wilson and J. Warkany, Eds.), p. 78. The University of Chicago Press, Chicago.
42. Kapron-Bras, C.M., and Trasler, D. G. (1984). Gene-teratogen interaction and its morphological basis in retinoic acid-induced mouse spina bifida. Teratology 30, 143-150.
43. Kapron-Bras, C.M., and Trasler, D. G. (1988). Interaction between the Splotch mutation and retinoic acid in mouse neural tube defects in vitro. Teratology 38, 165-173.
44. Kimmel, C. A., and Trammell, C. (1981). A rapid procedure for routine double staining of cartilage and bone in fetal and adult animals. Stain Technol. 56, 271-273.
45. Konyukhov, B. V., and Mironova, O. V. (1979). Interaction of the mutant genes splotch and fidget in mice. Genetika 15, 641-645.
46. Kuczuk, M. H., and Scott, W. J., Jr. (1984). Potentiation of acetazolamide induced ectrodactyly in SWV and C57BL/6J mice by cadmium sulfate. Teratology 29, 427-435.
47. Layton, W. M., Jr, and Layton, M. W. (1979). Cadmium-induced limb defects in mice: Strain-associated differences in sensitivity. Teratology 19, 229-236.
48. Leek, I. (1977). Correlations of malformation frequency with environmental and genetic attributes in man. In Handbook of Teratology (J. G. Wilson and F. Clarke Fraser, Eds.), pp. 243-324. Plenum Press, New York.
49. Maroto, M., Reshef, R., Munsterberg, A. E., Koester, S., Goulding, M., and Lassar, A. B. (1997). Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89, 139-148.
50. Moase, C. E., and Trasler, D. G. (1987). Retinoic acid-induced selective mortality of Splotch-delayed mouse neural tube defect mutants. Teratology 36, 335-343.
51. Moase, C. E., and Trasler, D. G. (1992). Splotch locus mouse mutants: Models for neural tube defects and Waardenburg syndrome type I in humans. J. Med. Genet. 29(3), 145-151.
52. Morrissey, R. E., and Mottet, N. K. (1983). Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation. Teratology 28, 399-411.
53. Naruse, I., Collins, M. D., and Scott, W. J., Jr. (1988). Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos. Teratology 38, 87-96.
54. National Research Council. (1994). Alternatives for ground water cleanup, p. 26. National Academy Press, Washington, D. C.
55. Read, A. P., and Newton, V. E. (1997). Waardenburg syndrome. J. Med. Genet. 34, 656-665.
56. Ridgeway, L. P., and Karnofsky, D. A. (1952). The effects of metals on the chick embryo: Toxicity and production of abnormalities in development. Ann. N Y Acad. Sci. 55, 203-215.
57. Rossman, T. G. (1998). Arsenic. In Environmental and Occupational Medicine. (W. N. Rom, Ed.), pp. 1011-1019. Lippincott-Raven Publishers, Philadelphia.
58. Russell, W. L. (1947). Splotch, a new mutation in the house mouse, Mus musculus. Genetics 32, 102.
59. Shalat, S. L., Walker, D. B., and Finnell, R. H. (1996). Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J. Toxicol. Environ. Health 48, 253-272.
60. Stumpo, D. J., Bock, C. B., Tuttle, J. S., and Blackshear, P. J. (1995). MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc. Natl. Acad. Sci. U S A 92, 944-948.
61. Tajbakhsh, S., Rocancourt, D., Cossu, G., and Buckingham, M. (1997). Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127-138.
62. Thomas, S. M., Moreno, R. F., and Tilzer, L. L. (1989). DNA extraction with organic solvents in gel barrier tubes. Nucleic Acids Res. 17, 5411.
63. Waardenburg, P. J. (1951). A new syndrome combining developmental anomalies of the eyelids, eyebrows, and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am. J. Hum. Genet. 3, 195-253.
64. Ward, K. W., Rogers, E. H., and Hunter, E. S. 3rd. (1998). Dysmorphogenic effects of a specific kinase C inhibitor during neurulation. Reprod. Toxicol. 12(5), 525-534.
65. Webster, W.S., and Edwards, M. J. (1984). Hyperthermia and the induction of neural tube defects in mice. Teratology 29, 417-425.
66. Wehr, R., and Gruss, P. (1996). Pax and vertebrate development. Int. J. Dev. Biol. 40, 369-377.
67. Willhite, C. C. (1981). Arsenic-induced axial skeletal (dysraphic) disorders. Exp. Mol. Pathol. 34, 145-158.
68. Willhite, C. C., and Ferm, V. H. (1984). Prenatal and developmental toxicology of arsenicals. Adv. Exp. Med. Biol. 177, 205-228.
69. Wilson, J. G. (1965). Embryological considerations in teratology. In Teratology: Principles and Techniques (J. G. Wilson and J. Warkany, Eds.), pp. 251-277. University of Chicago Press, Chicago.
70. Wilson, J. G. (1973). Environment and Birth Defects, p. 48. Academic Press, New York.
71. Wilson, J. G. (1977). Current status of teratology - general principles and mechanisms derived from animal studies. In Handbook of Teratology (J. G. Wilson and F. Clarke Fraser, Eds.), pp. 47-74. Plenum Press, New York.
72. Winski, S. L., and Carter, D. E. (1995). Interactions of rat blood cell sulfhydryls with arsenate and arsenite. J. Toxicol. Environm. Health 46, 379-397.
73. Wise, L. D., Beck, S. L., Beltrame, D., Beyer, B. K., Chahoud, I., Clark, R. L., Clark, R. (1997). Terminology of developmental abnormalities in common laboratory mammals (version 1). Teratology 55, 249-292.
74. Wlodarczyk, B. J., Bennett, G. D., Calvin, J. A., and Finnell, R. H. (1996). Arsenic-induced neural tube defects in mice: Alterations in cell cycle gene expression. Reprod. Toxicol. 10(6), 447-454.
75. Wu, M., Chen, D. F., Sasakoa, T., and Tonegawa, S. (1996). Neural tube defects and abnormal brain development in F52-deficient mice. Proc. Natl. Acad. Sci. U S A 93, 2110-2115.
76. Wu, M.-M., Kuo, T. L., Hwang, Y.-H., and Chen, C. J. (1989). Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130, 1123-1132.